#
info@crystallizationsummit.com
English
English
Bangla
French
Spanish
Arabic
Office Address
info@crystallizationsummit.com
Phone: +1 732-978-0828
Pinterest
Social List
Home
About
Purpose
Typical Attendees
Organizer
Programs
2024
Program Schedule
Venue
Poster Abstract Submission
2024 Speakers
Sponsors
Organizing Committee
2023
Program Schedule
Sponsors
2022
2022 Report
Program
2021
2021 Report
2020
2020 Report
Registration
2024 Registration
Courtesy Cancelation
Sponsors
2024
2023
2022
News Right Sidebar
Home
News Right Sidebar
2024 ,
2024-speakers ,
session-2-particle-engineering-to-address-formulation-challenge
Dr. Lotfi Derdour, GlaxoSmithKline
June 21, 2024
Gautam Chauhan
2024 ,
session-3-computational-applications-for-controlled-crystallization
Solid Form Design and Selection Utilizing Combined Experimental and Computational Techniques
May 22, 2024
Gautam Chauhan
2024 ,
session-3-computational-applications-for-controlled-crystallization
Dr. Rajni Miglani Bhardwaj, Pfizer
May 22, 2024
Gautam Chauhan
2024 ,
session-3-computational-applications-for-controlled-crystallization
Computer-aided solid form design: Current challenges, future opportunities
May 22, 2024
Gautam Chauhan
2024 ,
session-3-computational-applications-for-controlled-crystallization
Dr. Susan M. Reutzel-Edens, SuRE Pharma Consulting, LLC
May 22, 2024
Gautam Chauhan
2024 ,
session-3-computational-applications-for-controlled-crystallization
Crystal structure prediction for realistic pharmaceutical targets with AIMNet2 neural network potential
May 19, 2024
Gautam Chauhan
session-3-computational-applications-for-controlled-crystallization
Prof. Olexandr Isayev, Carneige Mellon University
May 19, 2024
Gautam Chauhan
2024 ,
session-3-computational-applications-for-controlled-crystallization
Fast-tracking Pharmaceutical Process Optimization with Small Data and Machine Learning
May 19, 2024
Gautam Chauhan
2024 ,
session-2-particle-engineering-to-address-formulation-challenge
Use of automation, dynamic image analysis, and process analytical technologies to enable data rich particle engineering efforts at the Drug Substance / Drug Product interface: A case study using Lovastatin
May 19, 2024
Gautam Chauhan
session-2-particle-engineering-to-address-formulation-challenge
Dr. Jeremy M. Merritt, Eli Lilly & Co.
May 19, 2024
Gautam Chauhan
1
2
3
4
5
…
10
11
12